BRIGHTON JONES LLC - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIGHTON JONES LLC ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$18,000
+20.0%
10,0000.0%0.00%0.0%
Q4 2021$15,000
-75.4%
10,000
-66.7%
0.00%
-66.7%
Q3 2021$61,000
-41.3%
30,0000.0%0.00%
-40.0%
Q2 2021$104,000
+477.8%
30,000
+200.0%
0.01%
+400.0%
Q1 2021$18,00010,0000.00%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Inspire Advisors, LLC 196,867$181,0000.05%
Wealth Advisory Solutions, LLC 156,850$144,0000.04%
Horst & Graben Wealth Management LLC 75,722$70,0000.02%
Ergoteles LLC 451,890$416,0000.01%
Miller Investment Management, LP 50,000$46,0000.01%
Virtu Financial LLC 81,410$75,0000.01%
Y-Intercept (Hong Kong) Ltd 17,342$16,0000.00%
Kestra Advisory Services, LLC 71,102$65,0000.00%
Csenge Advisory Group 15,000$14,0000.00%
Qube Research & Technologies Ltd 121,281$112,0000.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders